Capa, Vidie .
HRN: 14-41-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
01/02/2024
01/08/2024
PO
5.5ml
BID
PCAPC
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes